OUR MISSION
Precision neurology, delivered on its promise.
If you're advancing a CNS therapy, you're attempting one of the hardest things in medicine — and you deserve evidence built from the biology you'll be judged by: the individual human brain, not a population average.
NEXI exists as your guide across that gap. We build the human-relevant models that let you ask better questions earlier, so the right medicines reach the right patients faster — with your name on them.
Request a briefing
THE TRANSLATIONAL BOTTLENECK
The gap between the bench and the clinic.
CNS drug development fails more than almost any other field — and it fails late, after the capital is spent. The reason is upstream: the biology used to make early decisions doesn't behave like a human brain. That is the wall standing between your program and the clinic — and the wall we built NEXI to take down.
A translational bottleneck
Promising drug candidates stall before they ever reach patients — not for lack of ambition or capital, but because the science underneath doesn't carry over to humans.
Built on the wrong biology
Go / no-go decisions rely on animal models — primarily transgenic rodents engineered to imitate human brain disease. Mice aren't small humans, and their brains don't behave like ours.
A signal that doesn't hold
Investors and regulators need evidence that predicts the clinic. Animal data gives them confidence that too often evaporates the moment a candidate meets a human brain.
WHAT WE STAND FOR
Human-relevant by conviction, not convenience.
Patient-specific
Models built from the biology of real patients, for therapies that fit real patients.
Precision neurology
Resolving disease at the level of circuits — where neurology actually lives.
Translational by design
Evidence built to inform clinical decisions, not just publication figures.
IMPACT
A differentiated platform for the hardest problems in neuroscience.
Neurodegeneration & cognitive longevity
Advancing models that preserve and restore cognitive function across the aging trajectory.
Rare disease & neurodevelopmental
Capturing disease mechanisms that conventional systems miss, opening new paths for orphan indications.
Psychiatric & affective trauma
Building circuit-level resolution into models for conditions that have resisted every prior approach.
Our approach is highly differentiated, multi-faceted, and we are partnered with the leading technology developers across the globe.